drug

Blood samples for whole genomic/transcriptomic sequencing

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by University of British Columbia
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder
NCT02322918—Unknown
Adverse Events and Genomics in Schizophrenia
NCT01966588—Unknown

KOLs & investigators

1
Alasdair M Barr, Ph.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of British Columbia
company
trial
The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder
trial
Adverse Events and Genomics in Schizophrenia
trial
indication
Schizophrenia
indication
Psychosis
indication
Adverse Effect of Other Antipsychotics and Neuroleptics
indication
Schizophrenia
indication
KOL
Alasdair M Barr, Ph.D.
KOL score 5
person